Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert E Ratner

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
American Heart Journal|October 31, 2006
Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS)Marie Russell, Jerome L Fleg, Wm James Galloway, et al.
Diabetes Care|May 26, 2016
Evaluating the Quality of Comprehensive Cardiometabolic Care for Patients With Type 2 Diabetes in the U.S.: The Diabetes Collaborative RegistrySuzanne V Arnold, Silvio E Inzucchi, Darren K McGuire, et al.
Diabetes|July 19, 2013
Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlatesRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Diabetes Care|September 25, 2013
Prediction of diabetes based on baseline metabolic characteristics in individuals at high riskRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, et al.
The American Journal of Cardiology|July 28, 2004
Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study)Georgios I Papaioannou, Richard L Seip, Neil J Grey, et al.
Journal of Clinical Lipidology|June 22, 2010
Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) Charlton Wilson, Chun-Chih Huang, Nawar Shara, et al.
Diabetes Care|February 28, 2014
The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemiaLouise Bordeleau, Natalia Yakubovich, Gilles R Dagenais, et al.
Diabetes Care|September 25, 2014
Diabetic kidney disease: a report from an ADA Consensus ConferenceKatherine R Tuttle, George L Bakris, Rudolf W Bilous, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 24, 2012
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factorsAramesh Saremi, Dawn C Schwenke, Thomas A Buchanan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2014
Diabetic kidney disease: a report from an ADA Consensus ConferenceKatherine R Tuttle, George L Bakris, Rudolf W Bilous, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
American Heart Journal|October 31, 2006
Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS)Marie Russell, Jerome L Fleg, Wm James Galloway, et al.
Diabetes Care|May 26, 2016
Evaluating the Quality of Comprehensive Cardiometabolic Care for Patients With Type 2 Diabetes in the U.S.: The Diabetes Collaborative RegistrySuzanne V Arnold, Silvio E Inzucchi, Darren K McGuire, et al.
Diabetes|July 19, 2013
Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlatesRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, et al.
Diabetes Care|September 25, 2013
Prediction of diabetes based on baseline metabolic characteristics in individuals at high riskRalph A Defronzo, Devjit Tripathy, Dawn C Schwenke, et al.
The American Journal of Cardiology|July 28, 2004
Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study)Georgios I Papaioannou, Richard L Seip, Neil J Grey, et al.
Journal of Clinical Lipidology|June 22, 2010
Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) Charlton Wilson, Chun-Chih Huang, Nawar Shara, et al.
Diabetes Care|February 28, 2014
The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemiaLouise Bordeleau, Natalia Yakubovich, Gilles R Dagenais, et al.
Diabetes Care|September 25, 2014
Diabetic kidney disease: a report from an ADA Consensus ConferenceKatherine R Tuttle, George L Bakris, Rudolf W Bilous, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 24, 2012
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factorsAramesh Saremi, Dawn C Schwenke, Thomas A Buchanan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2014
Diabetic kidney disease: a report from an ADA Consensus ConferenceKatherine R Tuttle, George L Bakris, Rudolf W Bilous, et al.
Pageof 9